Healthcare -
Biotechnology - NASDAQ - US
$ 1.07
0.943 %
$ 18.2 M
Market Cap
-0.07
P/E
INCOME STATEMENT
EFFICIENCY
Earnings Waterfall
Allarity Therapeutics, Inc.
| Revenue | 0 |
| Cost Of Revenue | 0 |
| Gross Profit | 0 |
| Operating Expenses | 17.5 M |
| Operating Income | -27.2 M |
| Other Expenses | -2.73 M |
| Net Income | -24.5 M |
Income Statement
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0.1 | 1.5 | 1.5 | 0.1 | 0.4 | 9.97 K | 0 |
| GROSS PROFIT | ||||||||||||
| Cost Of Revenue | 0 | 37 K | 0.1 | 0.1 | 86 K | 0 | 5.1 | 2.2 | 0 | 0 | 55.8 K | 62.9 K |
| Gross Profit | 0 | 37 K | (0.1) | (0.1) | 86 K | 0.1 | (3.6) | (0.8) | 0.1 | 0.4 | 45.9 K | 62.9 K |
| OPERATING INCOME | ||||||||||||
| Operating Expenses | 17.5 | 17.9 | 16.9 | 26.6 | 9.2 | 10.2 | 1.4 | 3.1 | 4.6 | 1.8 | 22.8 K | 18.2 K |
| Selling, General and Administrative Expenses | 11.4 | 10.0 | 10.0 | 12.4 | 4.1 | 3.9 | 1.3 | 3.1 | 0.3 | 89.2 K | 0 | 0 |
| Research and Development Expenses | 6.1 | 7.9 | 6.9 | 14.2 | 5.1 | 6.4 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | (27.2) | (17.9) | (34.5) | (26.6) | (9.2) | (17.6) | (5.0) | (3.8) | (4.5) | (1.4) | 68.7 K | 81.2 K |
| PRE-TAX INCOME | ||||||||||||
| Interest Income Expense | (0.7) | 0.5 | 0.2 | 0.5 | 0.2 | 3.3 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income | 2.3 | 5.3 | (0.7) | 41 K | 1.9 | (8.9) | 1.5 | (1.1) | 38 K | (0.1) | 0 | 0 |
| Pre-Tax Income | (24.9) | (12.6) | (17.6) | (26.5) | (7.2) | (19.0) | (3.5) | (5.0) | (4.4) | (1.5) | 68.7 K | 81.2 K |
| NET INCOME | ||||||||||||
| Tax Provision | (0.4) | (0.7) | (1.5) | 0.1 | (2.2) | (4.6) | 1.1 | 95.1 K | 0.8 | 0.4 | 0 | 0 |
| Net Income | (24.5) | (11.9) | (16.1) | (26.6) | (5.1) | (14.4) | (2.3) | (4.9) | (3.7) | (1.1) | 68.7 K | 81.2 K |
| EPS | 0 | 0.0103 | (1.9) | (3.5) | (1.7) | (0.2) | 0 | 0 | 0 | 0 | 0.0587 | 0 |